Combining the amplification refractory mutation system and high-resolution melting analysis for KRAS mutation detection in clinical samples

The success of personalized medicine depends on the discovery of biomarkers that allow oncologists to identify patients that will benefit from a particular targeted drug. Molecular tests are mostly performed using tumor samples, which may not be representative of the tumor’s temporal and spatial het...

Descripción completa

Detalles Bibliográficos
Autores principales: Oliveira, Beatriz B., Costa, Beatriz, Morão, Barbara, Faias, Sandra, Veigas, Bruno, Pereira, Lucília Pebre, Albuquerque, Cristina, Maio, Rui, Cravo, Marília, Fernandes, Alexandra R., Baptista, Pedro Viana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10185647/
https://www.ncbi.nlm.nih.gov/pubmed/37097304
http://dx.doi.org/10.1007/s00216-023-04696-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10185647/
https://www.ncbi.nlm.nih.gov/pubmed/37097304
http://dx.doi.org/10.1007/s00216-023-04696-6

Ejemplares similares